home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.85 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

72 73 Next >

Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines? ↗

March 14, 2023

Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.

Via Benzinga

BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023

March 13, 2023

From BioNTech SE

Via GlobeNewswire

Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential ↗

March 10, 2023

They're both facing the same fierce headwind, and it won't be going away soon.

Via The Motley Fool

How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising ↗

March 03, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

February 20, 2023

Via Benzinga

Analyst Ratings for BioNTech ↗

January 24, 2023

Via Benzinga

European Commission Keeps Mum On Talks Regarding Pfizer COVID-19 Vaccine Contract: Report ↗

March 02, 2023

European Commission President Ursula von der Leyen remains silent on her dealings with Pfizer Inc (NYSE: PFE) regarding the EU's COVID-19 vaccine contract is hurting public trust.

Via Benzinga

BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel

March 01, 2023

From BioNTech SE

Via GlobeNewswire

The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks ↗

February 24, 2023

Startling cancer vaccine results from Moderna may point to the next big thing in biotech.

Via Investor's Business Daily

Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination ↗

February 24, 2023

Via Benzinga

Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop ↗

February 23, 2023

The company is doubling down on its vaccine success.

Via The Motley Fool

Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees ↗

February 17, 2023

Shares crumbled after Moderna's flu shot outperformed in just one flu strain.

Via Investor's Business Daily

Why Is Moderna (MRNA) Stock Down 5% Today? ↗

February 17, 2023

If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.

Via InvestorPlace

Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents ↗

February 17, 2023

Via Benzinga

Is Novavax Stock a Buy With the New Normal for COVID? ↗

February 10, 2023

The landscape has shifted dramatically in the COVID-19 vaccine market.

Via The Motley Fool

The 3 Most Undervalued Growth Stocks for Your February Buy List ↗

February 06, 2023

These undervalued growth stocks have the value and projected growth that investors seek when researching their next investment decisions.

Via InvestorPlace

Better Buy: Novavax or BioNTech Stock? ↗

February 04, 2023

The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.

Via The Motley Fool

The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗

February 02, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Via InvestorPlace

BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

February 02, 2023

From BioNTech SE

Via GlobeNewswire

Novavax Shares Jumped in January While Others Slipped

February 01, 2023

Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.

Via MarketBeat

Why BioNTech And Moderna Shares Are Falling After Pfizer News ↗

January 31, 2023

BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:

Via Benzinga

$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns ↗

January 30, 2023

The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.

Via Benzinga

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip ↗

January 27, 2023

The FDA's experts voted in favor of annual boosters on Thursday.

Via Investor's Business Daily

Mergers and Acquisitions in 2023 Off To A Strong Start

January 26, 2023

Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.

Via MarketBeat

Thursday Predictions: 3 Hot Stocks for Tomorrow ↗

January 25, 2023

Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.

Via InvestorPlace

COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today ↗

January 23, 2023

The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.

Via Benzinga

Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20 ↗

January 20, 2023

Here's a round-up of stories from around the globe and from various media outlets. Benzinga

Via Benzinga

Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots ↗

January 20, 2023

Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

Via Benzinga

Pfizer (PFE) Stock Falls on Analyst Downgrade ↗

January 17, 2023

Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.

Via InvestorPlace

Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares ↗

January 17, 2023

Shares have skidded almost 10% in the first two weeks of 2023.

Via Investor's Business Daily

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com